Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • BHP Group's shares are rated overweight by Morgan Stanley, citing attractive valuations and favorable commodity outlooks, particularly for iron ore and copper.
  • Mesoblast retains a speculative buy rating from Bell Potter, bolstered by a new J-Code in the US for Ryoncil, which enhances billing and reimbursement processes.
  • Web Travel Group is seen as undervalued by Macquarie, highlighting its strong trading update and confidence in reaching a $10 billion transaction target by FY 2030.

Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to the release of a number of broker notes this week.

Three ASX shares that brokers have named as buys this week are listed below. Here's why their analysts are feeling bullish on them right now:

BHP Group Ltd (ASX: BHP)

According to a note out of Morgan Stanley, its analysts have retained their overweight rating on this mining giant's shares with an improved price target of $48.00. The broker believes that ASX mining shares are trading on attractive valuations compared to industrials. And with the iron ore price historically performing well during a period of US dollar weakness, it feels this bodes well for BHP. In addition, it feels that copper has a bright outlook, which is also good news for the Big Australian. The BHP share price is trading at $41.93 on Wednesday.

Mesoblast Ltd (ASX: MSB)

A note out of Bell Potter reveals that its analysts have retained their speculative buy rating on this biotechnology company's shares with an improved price target of $4.00. This follows news that the CMS in the US has announced a specific J-Code for Ryoncil for billing and reimbursement from 1 October. Bell Potter highlights that the new permanent J-Code provides a standardised, clear, permanent, and specific billing pathway for Ryoncil by Medicaid, facilitating reimbursement and broader patient access. It feels that this means the December quarter is now shaping up as the breakout period. It also feels that its quarterly cash flow will show a large reduction in cash burn as cash inflows from product sales of Ryoncil commence. The Mesoblast share price is fetching $2.97 at the time of writing.

Web Travel Group Ltd (ASX: WEB)

Analysts at Macquarie have retained their outperform rating on this travel technology company's shares with an improved price target of $6.98. According to the note, Web Travel delivered a trading update slightly ahead of expectations. In light of this, the broker remains very positive on its outlook and is increasingly confident it will reach its $10 billion FY 2030 total transaction value target. And with UEBITDA margin visibility improving, the broker thinks its shares are cheap at current levels. In fact, Macquarie highlights that its shares are trading materially below its post-pandemic average multiples. It feels this is unjustified and represents a buying opportunity. The Web Travel share price is trading at $4.21 this afternoon.

Motley Fool contributor James Mickleboro has positions in Web Travel Group Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: Fortescue, Qantas, and WiseTech shares

Are these popular shares in the buy zone? Let's find out what analysts are saying.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Buy, hold, sell: Breville, Catalyst Metals, and Goodman shares

Let's see what analysts at Morgans are saying about these top stocks.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: Light & Wonder, NAB, and Woodside shares

Morgans has given its verdict on these popular stocks.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Resources Shares

2 ASX mining shares to buy for 2026

Macquarie has buy ratings on this ASX copper mining share and ASX gold mining stock.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Broker Notes

Buy, hold, sell: Amcor, ANZ, and Macquarie shares

Does a leading broker think investors should be buying these blue chips? Let's find out.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Buy, hold, sell: CBA, REA Group, and Xero shares

Morgans has given its verdict on these popular stocks. Let's see if it is bullish on them.

Read more »